Observational study / 2009
Higher plasma choline and vitamin B2 levels were linked to increased prostate cancer risk, while methylmalonic acid was inversely linked.
Researchers examined plasma concentrations of seven one-carbon metabolism components in 561 prostate cancer cases and 1,034 matched controls nested within the Northern Sweden Health and Disease Cohort. Doubling of plasma concentrations was linked to higher prostate cancer risk for choline (RR 1.46, 95% CI 1.04-2.05, P trend = 0.03) and vitamin B2 (RR 1.11, 95% CI 1.00-1.23, P trend = 0.04). In contrast, doubling of methylmalonic acid (MMA) was linked to lower risk (RR 0.78, 95% CI 0.63-0.97, P trend = 0.03). Concentrations of betaine, cysteine, methionine, and vitamin B6 were not associated with prostate cancer risk.
Shows an association, not proof of cause and effect.
- Study type
- Nested case-control study
- Who was studied
- 561 prostate cancer cases and 1,034 matched controls from the Northern Sweden Health and Disease Cohort
- What was measured
- Relative risk of prostate cancer in relation to circulating B vitamins and metabolites
THE PAPER
One-carbon metabolism and prostate cancer risk: prospective investigation of seven circulating B vitamins and metabolites.
Johansson M, Van Guelpen B, Vollset SE, Hultdin J, Bergh A, Key T, Midttun O, Hallmans G, Ueland PM, Stattin P. Cancer Epidemiol Biomarkers Prev, 2009.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.